Impact of Adjuvant Radiotherapy Setting on Quality-of-Life in Head and Neck Squamous Cell Carcinoma.
head and neck
quality-of-life
radiation therapy
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
revised:
20
02
2024
received:
29
12
2023
accepted:
23
02
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
aheadofprint
Résumé
To determine differences in post-treatment QoL across treatment settings in patients receiving adjuvant radiation therapy for head and neck squamous cell carcinoma (HNSCC). This was a prospective observational cohort study of patients with HNSCC initially evaluated in a head and neck surgical oncologic and reconstructive clinic at an academic medical center (AMC). Participants were enrolled prior to treatment in a prospective registry collecting demographic, social, and clinical data. Physical and social-emotional QoL (phys-QoL and soc-QoL, respectively) was measured using the University of Washington-QoL questionnaire at pre-treatment and post-treatment visits. A cohort of 177 patients, primarily male and White with an average age of 61.2 ± 11.2 years, met inclusion criteria. Most patients presented with oral cavity tumors (n = 132, 74.6%), had non-HPV-mediated disease (n = 97, 61.8%), and were classified as Stage IVa (n = 72, 42.8%). After controlling for covariates, patients treated at community medical centers (CMCs) reported a 7.15-point lower phys-QoL compared with those treated at AMCs (95% CI: -13.96 to -0.35, p = 0.040) up to 12 months post-treatment. Additionally, patients who were treated at CMCs had a 5.77-point (-11.86-0.31, p = 0.063) lower soc-QoL score compared with those treated at an AMC, which was not statistically significant. This study revealed that HNSCC patients treated with radiation at AMCs reported significantly greater phys-QoL in their first-year post-treatment compared to those treated at CMCs, but soc-QoL did not differ significantly. Further observational studies are needed to explore potential factors, including treatment planning and cancer resource engagement, behind disparities between AMCs and CMCs. Step 3 Laryngoscope, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233(9):780-786. https://doi.org/10.1038/s41415-022-5166-x.
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235-3242. https://doi.org/10.1200/jco.2015.61.6995.
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550-4559. https://doi.org/10.1200/jco.2013.50.3870.
D'Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One. 2014;9(1):e86023. https://doi.org/10.1371/journal.pone.0086023.
Yeh SA. Radiotherapy for head and neck cancer. Semin Plast Surg. 2010;24(2):127-136. https://doi.org/10.1055/s-0030-1255330.
Lassig AA, Joseph AM, Lindgren BR, et al. The effect of treating institution on outcomes in head and neck cancer. Otolaryngol Head Neck Surg. 2012;147(6):1083-1092. https://doi.org/10.1177/0194599812457324.
Chen AY, Pavluck A, Halpern M, Ward E. Impact of treating facilities' volume on survival for early-stage laryngeal cancer. Head Neck. 2009;31(9):1137-1143. https://doi.org/10.1002/hed.21072.
Chen AY, Fedewa S, Pavluck A, Ward EM. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116(20):4744-4752. https://doi.org/10.1002/cncr.25364.
Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301(25):1364-1369. https://doi.org/10.1056/nejm197912203012503.
Luft HS. The relation between surgical volume and mortality: an exploration of causal factors and alternative models. Med Care. 1980;18(9):940-959. https://doi.org/10.1097/00005650-198009000-00006.
Gutierrez JC, Perez EA, Moffat FL, Livingstone AS, Franceschi D, Koniaris LG. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245(6):952-958. https://doi.org/10.1097/01.sla.0000250438.04393.a8.
Khuri SF, Najjar SF, Daley J, et al. Comparison of surgical outcomes between teaching and nonteaching hospitals in the Department of Veterans Affairs. Ann Surg. 2001;234(3):370-382; discussion 382-3. https://doi.org/10.1097/00000658-200109000-00011.
Lee CC, Huang TT, Lee MS, et al. Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in Taiwan. Radiat Oncol. 2011;6:92. https://doi.org/10.1186/1748-717x-6-92.
Lee GC, Gamblin TC, Fong ZV, et al. Facility type is associated with margin status and overall survival of patients with resected intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2019;26(12):4091-4099. https://doi.org/10.1245/s10434-019-07657-5.
Wright JD, Chen L, Hou JY, et al. Association of hospital volume and quality of care with survival for ovarian cancer. Obstet Gynecol. 2017;130(3):545-553. https://doi.org/10.1097/aog.0000000000002164.
Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232(6):786-795. https://doi.org/10.1097/00000658-200012000-00007.
Xirasagar S, Lien YC, Lin HC, Lee HC, Liu TC, Tsai J. Procedure volume of gastric cancer resections versus 5-year survival. Eur J Surg Oncol. 2008;34(1):23-29. https://doi.org/10.1016/j.ejso.2007.08.002.
Cheung MC, Hamilton K, Sherman R, et al. Impact of teaching facility status and high-volume centers on outcomes for lung cancer resection: an examination of 13,469 surgical patients. Ann Surg Oncol. 2009;16(1):3-13. https://doi.org/10.1245/s10434-008-0025-9.
George JR, Yom SS, Wang SJ. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1118-1126. https://doi.org/10.1001/jamaoto.2013.4539.
Wuthrick EJ, Zhang Q, Machtay M, et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015;33(2):156-164. https://doi.org/10.1200/jco.2014.56.5218.
Koshy M, Malik R, Mahmood U, Husain Z, Sher DJ. Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer. Radiother Oncol. 2015;114(2):148-154. https://doi.org/10.1016/j.radonc.2014.12.004.
Naghavi AO, Echevarria MI, Strom TJ, et al. Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med. 2018;7(10):4964-4979. https://doi.org/10.1002/cam4.1756.
Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84-92. https://doi.org/10.3857/roj.2020.00213.
Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141(11):1985-1994. https://doi.org/10.1007/s00432-015-1974-6.
Tolentino Ede S, Centurion BS, Ferreira LH, Souza AP, Damante JH, Rubira-Bullen IR. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci. 2011;19(5):448-454. https://doi.org/10.1590/s1678-77572011000500003.
Urken ML, Jacobson AS, Lazarus CL. Comprehensive approach to restoration of function in patients with radiation-induced pharyngoesophageal stenosis: report of 31 patients and proposal of new classification scheme. Head Neck. 2012;34(9):1317-1328. https://doi.org/10.1002/hed.21927.
Seo MH, Eo MY, Myoung H, Kim SM, Lee JH. The effects of pentoxifylline and tocopherol in jaw osteomyelitis. J Korean Assoc Oral Maxillofac Surg. 2020;46(1):19-27. https://doi.org/10.5125/jkaoms.2020.46.1.19.
Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007;25(16):2191-2197. https://doi.org/10.1200/jco.2006.08.8005.
Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130(4):401-408. https://doi.org/10.1001/archotol.130.4.401.
Sharma Y, Mishra G, Parikh V. Quality of life in head and neck cancer patients. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 1):927-932. https://doi.org/10.1007/s12070-019-01620-2.
Farrugia M, Erickson K, Wendel E, et al. Change in physical performance correlates with decline in quality of life and frailty status in head and neck cancer patients undergoing radiation with and without chemotherapy. Cancers (Basel). 2021;13(7):7-11. https://doi.org/10.3390/cancers13071638.
Burckhardt CS, Anderson KL. The quality of life scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003;1:60. https://doi.org/10.1186/1477-7525-1-60.
Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci. 2014;16(2):137-145. https://doi.org/10.31887/DCNS.2014.16.2/mbullinger.
Gomes E, Aranha AMF, Borges AH, Volpato LER. Head and neck cancer patients' quality of life: analysis of three instruments. J Dent (Shiraz). 2020;21(1):31-41. https://doi.org/10.30476/dentjods.2019.77677.0.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.
Weymuller EA Jr, Alsarraf R, Yueh B, Deleyiannis FW, Coltrera MD. Analysis of the performance characteristics of the University of Washington Quality of life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg. 2001;127(5):489-493. https://doi.org/10.1001/archotol.127.5.489.
Kubicek GJ, Wang F, Reddy E, Shnayder Y, Cabrera CE, Girod DA. Importance of treatment institution in head and neck cancer radiotherapy. Otolaryngol Head Neck Surg. 2009;141(2):172-176. https://doi.org/10.1016/j.otohns.2009.03.019.
David JM, Ho AS, Luu M, et al. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer. Cancer. 2017;123(20):3933-3942. https://doi.org/10.1002/cncr.30843.
de Boer MF, van den Borne B, Pruyn JF, et al. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer. 1998;83(12):2567-2579.
Nordgren M, Jannert M, Boysen M, et al. Health-related quality of life in patients with pharyngeal carcinoma: a five-year follow-up. Head Neck. 2006;28(4):339-349. https://doi.org/10.1002/hed.20334.
Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA. Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol. 2008;26(16):2754-2760. https://doi.org/10.1200/jco.2007.12.9510.
Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes. 2009;7:102. https://doi.org/10.1186/1477-7525-7-102.
Ferris RL, Flamand Y, Weinstein GS, et al. Updated Report of a Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard Postoperative Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E3311). Wolters Kluwer Health; 2021.
Ma DJ, Price KA, Moore EJ, et al. Phase II evaluation of aggressive dose De-escalation for adjuvant Chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma. J Clin Oncol. 2019;37(22):1909-1918. https://doi.org/10.1200/jco.19.00463.
Swisher-McClure S, Lukens JN, Aggarwal C, et al. A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2020;106(4):725-732. https://doi.org/10.1016/j.ijrobp.2019.11.021.
Pearlstein KA, Wang K, Amdur RJ, et al. Quality of life for patients with favorable-risk HPV-associated oropharyngeal cancer after de-intensified chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2019;103(3):646-653. https://doi.org/10.1016/j.ijrobp.2018.10.033.
Tsai CJ, McBride SM, Riaz N, et al. Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive chemoradiotherapy. JAMA Oncol. 2022;8(3):364-372. https://doi.org/10.1001/jamaoncol.2021.6416.
Boero IJ, Paravati AJ, Xu B, et al. Importance of radiation oncologist experience among patients with head-and-neck cancer treated with intensity-modulated radiation therapy. J Clin Oncol. 2016;34(7):684-690. https://doi.org/10.1200/jco.2015.63.9898.
Seymour JW, Polsky DE, Brown EJ, Barbu CM, Grande D. The role of community health centers in reducing racial disparities in spatial access to primary care. J Prim Care Community Health. 2017;8(3):147-152. https://doi.org/10.1177/2150131917699029.
Taylor DB, Osazuwa-Peters OL, Okafor SI, et al. Differential outcomes among survivors of head and neck cancer belonging to racial and ethnic minority groups. JAMA Otolaryngol Head Neck Surg. 2022;148(2):119-127. https://doi.org/10.1001/jamaoto.2021.3425.
Baliga S, Yildiz VO, Bazan J, et al. Disparities in survival outcomes among racial/ethnic minorities with head and neck squamous cell cancer in the United States. Cancers (Basel). 2023;15(6):4-14. https://doi.org/10.3390/cancers15061781.
Nilsen ML, Moskovitz J, Lyu L, et al. Health literacy: impact on quality of life in head and neck cancer survivors. Laryngoscope. 2020;130(10):2354-2359. https://doi.org/10.1002/lary.28360.
Harley RJ, Atchison K, Li J, et al. Health literacy and adherence to clinical recommendations in head and neck cancer. Health Lit Res Pract. 2023;7(1):e52-e60. https://doi.org/10.3928/24748307-20230222-01.
Coughlin SS, Vernon M, Hatzigeorgiou C, George V. Health literacy, social determinants of health, and disease prevention and control. J Environ Health Sci. 2020;6(1):1-4.
Levy H, Janke A. Health literacy and access to care. J Health Commun. 2016;21(Suppl 1):43-50. https://doi.org/10.1080/10810730.2015.1131776.
Clarke JA, Despotis AM, Ramirez RJ, Zevallos JP, Mazul AL. Head and neck cancer survival disparities by race and rural-urban context. Cancer Epidemiol Biomark Prev. 2020;29(10):1955-1961. https://doi.org/10.1158/1055-9965.Epi-20-0376.
Ramprasad VH, Li J, Atchison K, et al. Quality of life in patients with recurrent and second primary head and neck cancer. Otolaryngol Head Neck Surg. 2023;168(2):196-202. https://doi.org/10.1177/01945998221087712.
Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138(2):123-133. https://doi.org/10.1001/archoto.2011.234.
Lang K, Menzin J, Earle CC, Jacobson J, Hsu MA. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg. 2004;130(11):1269-1275. https://doi.org/10.1001/archotol.130.11.1269.
Hakkarainen TW, Arbabi S, Willis MM, Davidson GH, Flum DR. Outcomes of patients discharged to skilled nursing facilities after acute care hospitalizations. Ann Surg. 2016;263(2):280-285. https://doi.org/10.1097/sla.0000000000001367.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. https://doi.org/10.3322/caac.21332.
Levy DA, Li H, Sterba KR, et al. Development and validation of nomograms for predicting delayed postoperative radiotherapy initiation in head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2020;146(5):455-464. https://doi.org/10.1001/jamaoto.2020.0222.
van der Meulen IC, May AM, de Leeuw JR, et al. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer. 2014;110(3):593-601. https://doi.org/10.1038/bjc.2013.733.
Semple C, Parahoo K, Norman A, McCaughan E, Humphris G, Mills M. Psychosocial interventions for patients with head and neck cancer. Cochrane Database Syst Rev. 2013;7:Cd009441. https://doi.org/10.1002/14651858.CD009441.pub2.
Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121-130. https://doi.org/10.1002/pon.3409.
Kangas M, Milross C, Taylor A, Bryant RA. A pilot randomized controlled trial of a brief early intervention for reducing posttraumatic stress disorder, anxiety and depressive symptoms in newly diagnosed head and neck cancer patients. Psychooncology. 2013;22(7):1665-1673. https://doi.org/10.1002/pon.3208.
Capozzi LC, McNeely ML, Lau HY, et al. Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: results from an exploratory randomized controlled exercise trial. Cancer. 2016;122(8):1185-1200. https://doi.org/10.1002/cncr.29863.
Lydiatt WM, Bessette D, Schmid KK, Sayles H, Burke WJ. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial. JAMA Otolaryngol Head Neck Surg. 2013;139(7):678-686. https://doi.org/10.1001/jamaoto.2013.3371.